We at anageninc provide this compound in a unique stable route of synthesis form which is extremely stable in solid and solution form which has been demonstrated by our R&D laboratory. The results are very encouraging which shows that the current anageninc route of synthesis is stable for at least 24 months at room temperature. Product Information: RU58841 (RU-58841) works by binding to the androgen receptor in the hair follicle. Therefore androgens don’t have the chance to bind and start the chain reaction of androgenetic alopecia and begin the so called miniaturization process. It has been demonstrated to interrupt this hair loss message locally so that normal hair growth could continue. Minoxidil is a vasodilator and has been shown to improve blood flow to the scalp, making Minoxidil a popular hair loss treatment. All cells that are multiplying and dividing to cause growth require a good supply of nutrients and oxygen which is provided by the blood. These two treatments work synergistically to reduce hair loss and promote hair regrowth, providing unrivalled and outstanding hair growth treatment. RU58841 stops androgens (DHT) from binding to the hair follicles and causing androgenic alopecia, it promotes regrowth of hairs from follicles that have become dormant and stops hair loss.

Since this medication is an anti-androgen, it may be able to target skin conditions such as acne and androgenic alopecia. However, the mechanism of RU58841 is entirely different from other anti-androgenic medications. And here is the reason:RU58841 is a specific androgen receptor antagonist or a so called anti-androgen. This non steroidal topical androgen antagonist was investigated for therapeutic value in androgenetic alopecia and acne. In studies and clinical trials RU58841 has shown to; RU58841 is a non-steroidal antiandrogenic medication that was initially developed in the 1980s as a topical treatment remedy for acne and male pattern baldness – androgenetic alopecia.